Notification about latest news from us.
Novo Nordisk lowers prices for Wegovy and Ozempic to $349 and introduces a $199 introductory rate, enhancing market competition in obesity treatments.
Eli Lilly seeks to join a lawsuit against the FDA regarding the marketing of its weight loss drug and the end of declared shortages.
By clicking send you'll receive occasional emails from newsletters about this topic.